Senator Grassley's Statement for the Record regarding FDA's Approval Process

The following press release was published by the United States Committee on Finance Ranking Member’s News on Feb. 16, 2006. It is reproduced in full below.

Please see the following two documents attached as related files:

(1) Grassley Statement from the Feb. 16 Congressional Record

(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression

Source: Ranking Member’s News